Research ArticleOncology
Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging
Aaron T. Mayer, Arutselvan Natarajan, Sydney R. Gordon, Roy L. Maute, Melissa N. McCracken, Aaron M. Ring, Irving L. Weissman and Sanjiv S. Gambhir
Journal of Nuclear Medicine April 2017, 58 (4) 538-546; DOI: https://doi.org/10.2967/jnumed.116.177659
Aaron T. Mayer
1Department of Bioengineering, Stanford University, Stanford, California
2Department of Radiology, Stanford University, Stanford, California
Arutselvan Natarajan
2Department of Radiology, Stanford University, Stanford, California
Sydney R. Gordon
3Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California
4Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford University, Stanford, California
5Stanford Cancer Institute, Stanford University, Stanford, California
6Department of Pathology, Stanford University, Stanford, California
Roy L. Maute
3Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California
4Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford University, Stanford, California
5Stanford Cancer Institute, Stanford University, Stanford, California
6Department of Pathology, Stanford University, Stanford, California
Melissa N. McCracken
3Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California
4Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford University, Stanford, California
5Stanford Cancer Institute, Stanford University, Stanford, California
6Department of Pathology, Stanford University, Stanford, California
Aaron M. Ring
7Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut; and
Irving L. Weissman
3Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California
4Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford University, Stanford, California
5Stanford Cancer Institute, Stanford University, Stanford, California
6Department of Pathology, Stanford University, Stanford, California
Sanjiv S. Gambhir
1Department of Bioengineering, Stanford University, Stanford, California
2Department of Radiology, Stanford University, Stanford, California
8Department of Materials Science & Engineering, Stanford University, Stanford, California

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 58, Issue 4
April 1, 2017
Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging
Aaron T. Mayer, Arutselvan Natarajan, Sydney R. Gordon, Roy L. Maute, Melissa N. McCracken, Aaron M. Ring, Irving L. Weissman, Sanjiv S. Gambhir
Journal of Nuclear Medicine Apr 2017, 58 (4) 538-546; DOI: 10.2967/jnumed.116.177659
Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging
Aaron T. Mayer, Arutselvan Natarajan, Sydney R. Gordon, Roy L. Maute, Melissa N. McCracken, Aaron M. Ring, Irving L. Weissman, Sanjiv S. Gambhir
Journal of Nuclear Medicine Apr 2017, 58 (4) 538-546; DOI: 10.2967/jnumed.116.177659
Jump to section
Related Articles
Cited By...
- Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy
- Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 2: The Role of Novel PET Agents
- 89Zr-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs
- ICOS Is an Indicator of T-cell-Mediated Response to Cancer Immunotherapy
- PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody
- ImmunoPET, [64Cu]Cu-DOTA-Anti-CD33 PET-CT, Imaging of an AML Xenograft Model
- AML ImmunoPET: 64Cu-DOTA-anti-CD33 PET-CT imaging of AML in Xenograft mouse model
- The Role of Radiation Oncology in Immuno-Oncology
- PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer
- The Immunoimaging Toolbox
- Optimizing Strategies for Immune Checkpoint Imaging with Immuno-PET in Preclinical Study
- Reply: Optimizing Strategies for Immune Checkpoint Imaging with Immuno-PET in Preclinical Study